<DOC>
	<DOCNO>NCT01305239</DOCNO>
	<brief_summary>Observational survey aim evaluate tolerability Aromasin way use clinical practice France ( adjuvant endocrine therapy ) .</brief_summary>
	<brief_title>A Survey Of Clinical Practice Of Adjuvant Treatment Of Breast Cancer Using Exemestane ( Aromasin® ) In Postmenopausal Hr+ Patients</brief_title>
	<detailed_description>It hypothesize 200 participating doctor would provide survey sufficient statistical precision meet objective , participate doctor recruit 6 patient . An initial sample 1000 doctor contact ( letter , phone ) . These 1000 doctor initially choose random file hold Pfizer doctor agree take part Pfizer survey . These doctor experience qualified treatment management patient non-metastatic , surgically-treated breast cancer ( medical oncologist , gynaecologist , medical oncologists/ radiation oncologist ) . They practice general hospital , teach hospital , CRLCC cancer centre private clinic treat patient breast cancer . Study recruitment stop due difficulty enrol targeted number patient December 3 , 2010 . There safety concern involve decision stop enrollment .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Exemestane</mesh_term>
	<criteria>Postmenopausal patient , define : natural menopause least 1 year , surgical ovariectomy , chemotherapyinduced amenorrhoea least 2 year . Patients surgical treatment histologically confirm breast cancer nonmetastatic time initial diagnosis . Patients whose tumour hormone receptor positive ( HR+ , ER+ and/or PR+ ) . Patients initiated Aromasin least 2 month inclusion 1 year . Patients Aromasin treatment contraindicate . Presence metastasis contralateral tumour . Another adjuvant endocrine therapy . Another concomitant antineoplastic treatment ( except Herceptin® ) . Participation clinical trial investigational drug 30 day prior enrolment study .</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Observational</keyword>
	<keyword>epidemiological</keyword>
	<keyword>cohort</keyword>
	<keyword>cross-sectional</keyword>
	<keyword>prospective</keyword>
	<keyword>multicenter</keyword>
	<keyword>survey</keyword>
	<keyword>France .</keyword>
</DOC>